ANTACID - TAB 327.8 MG
CALCIUM CARBONATE : 327.8 MG MAGNESIUM CARBONATE : 172.2 MG · DIN 02217783 · SWISS HERBAL REMEDIES LTD.
Health Canada status: CANCELLED POST MARKET
What is ANTACID - TAB?
ANTACID - TAB 327.8 MG contains CALCIUM CARBONATE : 327.8 MG MAGNESIUM CARBONATE : 172.2 MG. It is listed in the Health Canada Drug Product Database under DIN 02217783, held by SWISS HERBAL REMEDIES LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02217783 |
|---|---|
| Brand name | ANTACID - TAB |
| Generic / active ingredient | CALCIUM CARBONATE : 327.8 MG MAGNESIUM CARBONATE : 172.2 MG |
| Manufacturer | SWISS HERBAL REMEDIES LTD. |
| Strength | 327.8 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AD01 ORDINARY SALT COMBINATIONS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Sep-2003 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02217783 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2217783 |
| Brand name | ANTACID - TAB |
| Active ingredient / INN | CALCIUM CARBONATE : 327.8 MG MAGNESIUM CARBONATE : 172.2 MG |
| ATC code | A02AD01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | SWISS HERBAL REMEDIES LTD. |
Which pack is which?
| Strength on the label | 327.8 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A02AD01 ORDINARY SALT COMBINATIONS. 0 of 43 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACIDEX TC ORAL SUSPENSION | 600 MG / 5 ML | SUSPENSION | GEN DRUG COMPANY LTD. | CANCELLED POST MARKET | DIN 00742309 |
| AMPHOJEL 500 SUSPENSION | 500 MG / 5 ML | SUSPENSION | AXCAN PHARMA INC | CANCELLED POST MARKET | DIN 02125854 |
| AMPHOJEL PLUS SUSPENSION | 300 MG / 5 ML | SUSPENSION | AXCAN PHARMA INC | CANCELLED POST MARKET | DIN 02125005 |
| AMPHOJEL PLUS TABLETS | 300 MG | TABLET | AXCAN PHARMA INC | CANCELLED POST MARKET | DIN 02124998 |
| ANTACID | 174 MG / 5 ML | SUSPENSION | WES PAK PRODUCTS LTD. | CANCELLED POST MARKET | DIN 02231621 |
| ANTACID - ALUMINA AND MAGNESIA ORAL SUSPENSION USP | 225 MG / 5 ML | SUSPENSION | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 01927426 |
| ANTACID MAGNESIA AND ALUMINA | 200 MG / 5 ML | SUSPENSION | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 00854611 |
| ANTACID SUS | 200 MG / 5 ML | SUSPENSION | KSL PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00849138 |
| ANTIACIDE SUS | 200 MG / 5 ML | SUSPENSION | PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00873470 |
| CENTRA ACID-SUS | 200 MG / 5 ML | SUSPENSION | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | DIN 02141183 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.